162 results
Page 3 of 9
DEFC14A
cp6 bvsqxguc7u
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
5llnw0
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
rwapy4kiczrezl5s
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
fe2vtqh 9oafioir
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
5kyazx wdo65kft
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
S-8
93t1f
12 Aug 22
Registration of securities for employees
4:06pm
S-8
EX-5.1
khn mh68re
12 Aug 22
Registration of securities for employees
4:06pm
S-8
phpixabrv
12 Aug 22
Registration of securities for employees
4:06pm
424B5
3tv3ckay7gu31
22 Jul 22
Prospectus supplement for primary offering
4:15pm
8-K
nkycqv9bh9m88
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
th9nh7e qzpm
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
S-8
EX-4.8
1f6pt j3scl2le
12 Aug 21
Registration of securities for employees
4:50pm